Oulu University Hospital

Paediatric emergency care

Clinical research at Oulu University Hospital includes paediatric emergency medicine focused on managing minor painful procedures in children, with attention to sedation and analgesia during urgent care.

  • Intranasal dexmedetomidine
  • Procedure-related pain relief
  • Emergency room sedation

The research interest centers on supporting children undergoing brief invasive procedures such as i.v. cannulation and lumbar puncture.

Primary central nervous system lymphoma

The hospital also studies primary CNS lymphoma, including care for patients with newly diagnosed disease and those with relapsed or refractory lymphoma, with emphasis on neuro-oncology and hematologic malignancy care.

  • Primary CNS lymphoma
  • Relapsed and refractory disease
  • Neuro-oncology

Research activity in this area is linked to treatment strategies for aggressive lymphoma involving the central nervous system.

Chemoimmunotherapy

Another therapeutic focus is chemoimmunotherapy, reflecting interest in combined oncology and immunotherapy approaches for difficult-to-treat malignancies.

  • Combined cancer therapy
  • Immunotherapy
  • Hematologic cancer treatment

This area connects to clinical care for patients with lymphoma requiring advanced systemic treatment.

Blood-brain barrier opening

Research activity also includes blood-brain barrier opening, a specialised area relevant to delivering treatment for central nervous system malignancies and improving access to affected brain tissue.

  • Blood-brain barrier
  • Targeted CNS drug delivery
  • Brain-directed therapy

This topic aligns with the hospital’s work in neurologic oncology and complex lymphoma care.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Intranasal Dexmedetomidine for Sedation and Pain Relief in Children Undergoing Minor Procedures in the Emergency Room

    Recruiting

    1 1 1
    Finland
  • Study on the Effectiveness of Etoposide Phosphate, Carboplatin, Methotrexate, Rituximab, and Cyclophosphamide in Patients with Primary Central Nervous System Lymphoma

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Finland